According to the results of a survey conducted by the research company Active Group and the Experts Club analytical center and published in the Interfax-Ukraine press center, when buying medicines, 50.5% of respondents primarily focus on the combination of price and effectiveness, 25.0% on price, and 24.5% on effectiveness.
The survey was conducted online on February 11-12, 2026, with 1,000 respondents (18+).
“The choice of ‘price plus effectiveness’ reflects the desire to get results, but within a limited budget,” said Experts Club founder Maxim Urakin.
“Consumers are becoming more rational, and this intensifies competition among manufacturers for trust and affordability,” said Active Group CEO and co-founder Alexander Pozniy.
The study was conducted on the SunFlowerSociology online panel using a representative sample on February 11-12, 2026. The survey involved 1,000 respondents from a representative sample in all regions of Ukraine, except for the temporarily occupied territories.
ACTIVE GROUP, EXPERTS CLUB, Pozniy, SOCIOLOGY, SOLONINKA, SURVEY, URAKIN
